OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response...14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Xybernaut Corp.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
984149-10-4
----------------------------------------------
(CUSIP Number)
Checkthe appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
- --------------------- ----------------------
CUSIP No. 984149-10-4 13G PAGE 2 OF 5 PAGES
--- ---
- --------------------- ----------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven A. Newman, M.D.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 1,855,431
OWNED BY ----------------------------------------------------
EACH
REPORTING
PERSON 6 SHARED VOTING POWER
WITH
N/A
----------------------------------------------------
7 SOLE DISPOSITIVE POWER
1,855,431
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
N/A
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,855,431
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.1%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- --------------------- ----------------------
CUSIP No. 984149-10-4 13G PAGE 3 OF 5 PAGES
--- ---
- --------------------- ----------------------
ITEM 1(A). NAME OF ISSUER:
Xybernaut Corp.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
12701 Fair Lakes Circle
Fairfax, Virginia
ITEM 2(A). NAME OF PERSON FILING:
Steven A. Newman, M.D.
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
12701 Fair Lakes Circle
Fairfax, Virginia
ITEM 2(C). CITIZENSHIP:
United States of America
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock, $.01 par value per share
ITEM 2(E). CUSIP NUMBER:
984149-10-4
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
Not Applicable
<PAGE>
- --------------------- ----------------------
CUSIP No. 984149-10-4 13G PAGE 4 OF 5 PAGES
--- ---
- --------------------- ----------------------
ITEM 4. OWNERSHIP. As of December 31, 1999:
(a) Amount beneficially owned: 1,855,431 shares of Common Stock.
(b) Percent of Class: 6.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote: 1,855,431
(ii) shared power to vote or direct the vote: N/A
(iii) sole power to dispose or direct the disposition of: 1,855,431
(iv) shared power to dispose or direct the disposition of: N/A
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following: [ ].
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
The number of shares listed as beneficially owned by Dr.
Newman (1,855,431) includes: (i) 571,750 shares issuable upon
exercise of currently exercisable options; (ii) 100,000 shares
beneficially owned by an irrevocable trust established by Dr.
Newman for the benefit of his children; and (iii) 500,000
shares registered under the name of Bear Sterns pursuant to a
pledge agreement between Dr. Newman and Bear Sterns.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not Applicable
<PAGE>
- --------------------- ----------------------
CUSIP No. 984149-10-4 13G PAGE 5 OF 5 PAGES
--- ---
- --------------------- ----------------------
ITEM 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are held in
the ordinary course of business and were not acquired and are not held
for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction
having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
Dated: February 14, 2000
/s/ Steven A. Newman
--------------------
Steven A. Newman
